Products

PεMVISH

Master Your Enterprise Architecture with NuVision

pemvish.com Business Operations / IT & SaaS Management

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
Subscription model, plan pricing not identified yet
Creators
PεMVISH
No social account linked
Launched
4mo ago
2026-07-23 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    AI-Powered Enterprise Architecture & IT Asset Management

    Jul 23 · 4mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

No traffic channel or country breakdown data for this website yet.

Search

Domain authority —Domain registered Unknown

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Enterprise Architecture
Unknown
Centralized Application Portfolio
Unknown

Trial: None · Enterprise custom tier · Observed 2026-11-08 · Pricing page

Pages & changes

Tracked since 2026-07-23

Key pages

Weekly snapshots
pemvish.com/ Snapshot 2026-11-09

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does PεMVISH cost?
Enterprise Architecture: Unknown; Centralized Application Portfolio: Unknown. Observed 2026-11-08. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does PεMVISH get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is PεMVISH and what platforms does it support?
PεMVISH is catalogued under IT & SaaS Management: Master Your Enterprise Architecture with NuVision. Supported platforms: Web.

Related products in this category

Business Operations / IT & SaaS Management

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.